Clinical Trials
26 trialsNCT07593339 2026-05-18
Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery
Başakşehir Çam & Sakura City Hospital
Phase NA Not yet recruiting
NCT06476639 2026-03-24
ANVU
Queensland Centre for Gynaecological Cancer
Phase 3 Not yet recruiting
NCT07164534 2026-02-04
CHOC-LATE
Tata Memorial Hospital
Phase 3 Not yet recruiting
NCT07362147 2026-01-23
Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life
Taipei Veterans General Hospital, Taiwan
Phase NA Not yet recruiting
NCT07245381 2025-11-24
Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation
Sheba Medical Center
Phase 1/2 Not yet recruiting
NCT07077980 2025-07-22
Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines
Anhui Provincial Hospital
Not yet recruiting
NCT07068464 2025-07-16
ICRA
NHS Grampian
Phase 3 Not yet recruiting
NCT06602063 2025-06-27
Surgery for Relapsed Ovarian Cancer in Precision
Shanghai Gynecologic Oncology Group
Phase 1/2 Not yet recruiting
NCT06846424 2025-02-26
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Shanghai Gynecologic Oncology Group
Phase 1 Not yet recruiting
NCT06838429 2025-02-20
PARPi and Ovarian Cancer Survival
Shanghai Gynecologic Oncology Group
Not yet recruiting
NCT06760676 2025-01-07
A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT06745427 2024-12-20
PreFerEC/EIN
Region Stockholm
Not yet recruiting
NCT06673511 2024-11-21
The Application of Sentinel Lymph Node Mapping Technique in the Surgery of Early Epithelial Ovarian Cancer
Anhui Provincial Hospital
Phase NA Not yet recruiting
NCT06600841 2024-09-19
Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06542549 2024-08-07
Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer
Anhui Provincial Hospital
Phase 3 Not yet recruiting
NCT06539091 2024-08-06
Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer
Anhui Provincial Hospital
Phase 3 Not yet recruiting
NCT06456112 2024-07-01
Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV
Anhui Provincial Hospital
Not yet recruiting
NCT06415500 2024-05-16
A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT06242392 2024-02-05
The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
Fujian Cancer Hospital
Not yet recruiting
NCT06066216 2024-01-23
Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06197126 2024-01-09
MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy
Fujian Cancer Hospital
Not yet recruiting
NCT06149767 2023-11-29
Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06126393 2023-11-15
MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer
Fujian Cancer Hospital
Not yet recruiting
NCT06101966 2023-10-26
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
Fujian Cancer Hospital
Not yet recruiting
NCT06039982 2023-09-26
A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer
Fujian Cancer Hospital
Not yet recruiting
NCT04515602 2020-08-27
FOCUS
Shanghai Gynecologic Oncology Group
Phase 3 Not yet recruiting